Issue of warrants

 
TIDMRGT 
 
18 February 2011 
ReGen Therapeutics Plc 
(the "Company") 
to be renamed Alexander David Investments PLC 
 
                               Issue of warrants 
 
Further  to the placing of 300,000,000 new  ordinary shares of 0.01 pence in the 
Company  ("Ordinary  Shares")  at  0.5 pence  per  share  (the "Placing Shares") 
announced  earlier today, the Company  has issued one new  warrant for every ten 
Placing  Shares held.  This equates  to the  issue of  warrants over 30,000,000 
shares. Each warrant entitles the holder to subscribe for one new Ordinary Share 
in  the Company at  an exercise price  of 0.5 pence per  share. The warrants are 
exercisable until 18 February 2013. 
 
The total number of warrants now in issue is 155,388,604, comprising: 
 
+---------------------------+------------------+--------------+----------------+ 
|Warrantholder              |Number of warrants|Exercise price|Expiry date     | 
|                           |                  |              |                | 
+---------------------------+------------------+--------------+----------------+ 
|Pre-placing shareholders1  |         8,944,086|          0.5p|18 February 2013| 
|                           |                  |              |                | 
+---------------------------+------------------+--------------+----------------+ 
|Placing shareholders2      |        30,000,000|          0.5p|18 February 2013| 
|                           |                  |              |                | 
+---------------------------+------------------+--------------+----------------+ 
|Alexander  David Securities|       116,444,518|          0.5p|18 February 2016| 
|Limited                    |                  |              |                | 
|                           |                  |              |                | 
+---------------------------+------------------+--------------+----------------+ 
 
1 Shareholders in the Company as at 14 February 2011 
2 Participants in the placing announced on 18 February 2011 
 
 
 
 
 
Enquiries: 
 
 ReGen Therapeutics Plc               [phone] 
 Percy Lomax 
 
 
 Cairn Financial Advisers LLP         [phone] 
 Nominated Adviser 
 Liam Murray / Avi Robinson 
 
 
 Alexander David Securities Limited   [phone] 
 Broker 
 David Scott / Nick Bealer 
 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: ReGen Therapeutics Plc via Thomson Reuters ONE 
 
[HUG#1490556]